Skip to main content
SpringerLink
Log in

News from ESC

  • Meeting report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Burkard T, Kaiser C, Rocca HPB-L, Pfisterer M, Jeger R.Concomitant proton pump inhibitor therapy is associated with higher myocardial infarction rates after percutaneous coronary intervention. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. 5066, 28 Aug 2010. Available from: URL: http://www.escardio.org

  2. Charlot M, Grove EL, Hansen PR, Andersson C, Ahlehoff O, Olesen JB, Hansen ML, Fosbol EL, Torp-Pedersen C, Gislason GH.Proton pump inhibitors but not H-2 receptor blockers increase risk of adverse cardiovascular events in aspirin-treated patients with myocardial infarction: A nationwide propensity-score matched study. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. 5065, 28 Aug 2010. Available from: URL: http://www.escardio.org

  3. Westenbrink BD, Kleijn L, de Boer RA, Warnica WJ, Baillot R, Rouleau JL, van Gilst WH.Angiotensin converting enzyme inhibitors slow post-operative recovery from anemia and increase cardiovascular events after coronary artery bypass grafting. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. P525, 28 Aug 2010. Available from: URL: http://www.escardio.org

  4. Fosbol E, Andersson C, Weeke P, Olesen JB, Kober L, Torp-Pedersen C, Gislason GH.Use of non-steroidal anti-inflammatory drugs is associated with increased risk of stroke among healthy individuals. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. 3743, 28 Aug 2010. Available from: URL: http://www.escardio.org

  5. New Zealand Herald.Study links Voltaren to strokes. Internet Document: [1 page], 14 Sep 2010. Available from: URL: http://www.nzherald.co.nz

  6. J Emberson On Behalf Of The Cholesterol Treatment Trialists’ Collaboration.Safety of statin therapy: meta-analysis of data on cancer from 166 000 participants in 25 randomised trials. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. 5035, 28 Aug 2010. Available from: URL: http://www.escardio.org

  7. Chatzistamatiou E, Liakos C, Antoniadou A, Moustakas G, Kalovidouris N, Rodolakis N, Vagena IB, Bakogiannis C, Stefanadis C, Kallikazaros I.Risk factors for peripheral edema development in hypertensive patients treated with dihydropyridine calcium channel blockers - the smoking paradox. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. P3163, 28 Aug 2010. Available from: URL: http://www.escardio.org

  8. Liew D, Meerding WJ, Ong S, Webb K.The health and economic impact of switching from atorvastatin to generic simvastatin in the Netherlands. ESC Congress 2010: Annual Congress of the European Society of Cardiology: abstr. P1440, 28 Aug 2010. Available from: URL: http://www.escardio.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from ESC. React. Wkly. 1320, 4–5 (2010). https://doi.org/10.2165/00128415-201013200-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013200-00009

Keywords

Search

Navigation